characteristics.text: SAMN33411802
characteristics.characteristic: External Id
characteristics.text: Biomedical Engineering, Columbia University
characteristics.characteristic: INSDC center name
characteristics.text: 2023-03-11T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-03-11T01:12:27.930Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS16861510
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS16861510
characteristics.characteristic: SRA accession
characteristics.text: GBM4, GBM8, GSC0131 and GSC0827 cells
characteristics.characteristic: cell line
characteristics.text: Human glioblastoma brain cancer cells
characteristics.characteristic: cell type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: GBM4, GBM8, GSC0131 and GSC0827 cells
characteristics.characteristic: source_name
characteristics.text: sciPlex_3
characteristics.characteristic: title
characteristics.text: Cells were treated with increasing doses of the small molecules Lapatinib, Nintedanib, Trametinib, ZSTK474 or dmso vehicle control.
characteristics.characteristic: treatment